Tumor Necrosis Factor Receptor-Associated Factor 5 Promotes Arterial Neointima Formation through Smooth Muscle Cell Proliferation-Reference-Cited by-同舟云学术

Tumor Necrosis Factor Receptor-Associated Factor 5 Promotes Arterial Neointima Formation through Smooth Muscle Cell Proliferation

Published:2019 Issue:6 Volume:56 Page:308-319
ISSN:1018-1172
Container-title:Journal of Vascular Research
language:en
Short-container-title:J Vasc Res

Author:

Willecke Florian,Rupprecht Benjamin,Gissler Mark Colin,Pfeiffer Katharina,Anto-Michel Nathaly,Stachon Peter,Wolf Dennis,Hilgendorf Ingo,Hoppe Natalie,Bode Christoph,Zirlik Andreas

Publisher

S. Karger AG

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference41 articles.

1. Libby P. Inflammation in atherosclerosis. Nature. 2002 Dec;420(6917):868–74.

2. Donners MM, Daemen MJ, Cleutjens KB, Heeneman S. Inflammation and restenosis: implications for therapy. Ann Med. 2003;35(7):523–31.

3. Hassan GS, Merhi Y, Mourad W. CD40 ligand: a neo-inflammatory molecule in vascular diseases. Immunobiology. May;217(5):521–32.

4. Gerdes N, Zirlik A. Co-stimulatory molecules in and beyond co-stimulation - tipping the balance in atherosclerosis? Thromb Haemost. 2011 Nov;106(5):804–13.

5. Michel NA, Zirlik A, Wolf D. CD40L and Its Receptors in Atherothrombosis-An Update. Front Cardiovasc Med. 2017 Jun;4:40.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Regulation by TNF Receptor-associated Factor 5;YAKUGAKU ZASSHI;2024-05-01

2. Silencing of TRAF5 enhances necroptosis in hepatocellular carcinoma by inhibiting LTBR-mediated NF-κB signaling;PeerJ;2023-06-22

3. A review of the current state in neointimal hyperplasia development following endovascular intervention and minor emphasis on new horizons in immunotherapy;Translational and Clinical Pharmacology;2023

4. The Role of Tumor Necrosis Factor Associated Factors (TRAFs) in Vascular Inflammation and Atherosclerosis;Frontiers in Cardiovascular Medicine;2022-02-17